pharmaphorum

AUGUST 2, 2016

Join us for a one-hour live debate on Cancer Treatment Access: Right Strategy, Right Approach, Right Outcomes. To ensure funding and patient access to innovative cancer therapies, industry now have to navigate a new English cancer-treatment funding ecosystem, engaging with NICE and NHS England to realise a yes, no or conditional arrangement. How can oncology treatments achieve a positive NICE appraisal in the new world and what will the mechanics of RWE be in the event of conditional funding via

Drugs 52

Drugs Marketing 52

Research Ethics Blog

AUGUST 13, 2016

The Zika Virus – Image by David Goodwill (RCSB Molecule of the Month 197, June 2016). [CC BY 4.0 ( [link] )%5D, via Wikimedia Commons. A recent PBS Newshour story highlights just some of the challenges in getting a vaccine for Zika tested and out on the market. The article confirms that about 30 vaccines are being developed and tested. Currently there is a multi-centre open-label Phase 1 clinical trial underway using the GLS-5700 vaccine, developed by Inovio.

Vaccine 40

Vaccine Vaccination Development Marketing 40